Where does Affera, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Affera, Inc. ranks #7,513 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Affera, Inc. hold?

Affera, Inc. holds 43 US utility patents granted between 2018 and 2025, spanning 7 technology areas.

What is Affera, Inc.'s Innovation Score?

Affera, Inc. has an Innovation Score of 43.9 out of 100 (top 27% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Affera, Inc. focus on?

Affera, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 38 patents, ranking #502 of 7,127 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Affera, Inc.'s patent grant rate increasing or decreasing?

Affera, Inc.'s recent grant velocity is +211% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Affera, Inc.'s patents?

Affera, Inc.'s patents average 17.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Affera, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Affera, Inc.

USPTO PatentsView assignee record - 43 granted patents across 7 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Affera ranks #7,513 of 49,997 tracked US assignees by granted-patent volume, with 43 patents across 7 technology areas.

#7,513
of 49,997 US assignees by volume: Top 27%
by Innovation Score (43.9/100): 17.8
avg claims per patent: +211%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7513 · US Corporation #7,513 · 43 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 43 grants
UPPER-Q #7,513/49,997
PHOTO-FINISH 1more
CPC-NARROW A61B · 7 areas
INNOV-PAR 43.9/100
CLAIMS-RICH 17.8 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +211% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: 1more Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Affera’s 43.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.1 pts (30%) Velocity 10.8 pts (25%) Breadth 9.4 pts (21%) Claim depth 10.7 pts (24%)

Qualcomm Incorporated · highest

85
Affera · this assignee

44
Henry Ford Health… · near

44
Zoom Communications · near

44
Acetylon Pharmaceuti… · near

44
Panavision Internati… · near

44
3D Lighting… · lowest

7

What this shows Affera's Innovation Score is 43.9/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Affera?

Each dot is one of Affera’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Affera’s own 17.8 claims/patent is ABOVE the 8.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Affera vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Affera's grants concentrate

Affera, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 88.4% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (11 grants) versus a trough of 2 in 2021. By volume, Affera sits between Xcelsis Corporation and Array Technologies, Inc..

Affera's three-year grant acceleration

Affera, Inc. shows 21 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Xcelsis

44
Yangtze University

44
Zhejiang Super Li…

44
1more

43
Aiphone

43
Aira

43
Apaq Technology

43
Array

43
Affera ◀

43

What this shows Affera holds 43 patents at rank #7,512, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Affera

By rank, the assignees closest to #7,512 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Affera's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Affera, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Affera ranks #502 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (44 here).

Henry Ford Health System 44 Zoom Communications, Inc. 44 Panavision International, L.P. 44 Acetylon Pharmaceuticals, Inc. 44

Affera's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Affera, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	3	7.0%
2019	6	14.0%
2020	5	11.6%
2021	2	4.7%
2022	4	9.3%
2023	6	14.0%
2024	11	25.6%
2025partial year	6	14.0%

Which technologies does Affera, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 38

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 27

G06T - Image Data Processing OR Generation, IN General 8

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 4

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 2

G06F - Electric Digital Data Processing 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Affera, Inc.'s patent record in context - here's where to go next.

Affera, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 88.4% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #7,513 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Affera, Inc. against Xcelsis Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.